Levofloxacin plus Metronidazole Administered Once Daily versus Moxifloxacin Monotherapy against a Mixed Infection of Escherichia coli and Bacteroides fragilis in an In Vitro Pharmacodynamic Model

Moxifloxacin has been suggested as an option for monotherapy of intra-abdominal infections. Recent data support the use of a once-daily metronidazole regimen. The purpose of this study was to investigate the activity of levofloxacin (750 mg every 24 h [q24h]) plus metronidazole (1,500 mg q24h) compa...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Hermsen, Elizabeth D., Hovde, Laurie B., Sprandel, Kelly A., Rodvold, Keith A., Rotschafer, John C.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Society for Microbiology 2005
Gaiak:
Experimental Therapeutics
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC547281/
https://ncbi.nlm.nih.gov/pubmed/15673752
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.49.2.685-689.2005
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak